Clinical trial for Coronary Artery Disease
Official title Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
ClinicalTrials.gov ID: NCT07087431
What this study is testing
- What it's testing
- The study wants to see whether telling participants their polygenic risk score for coronary artery disease leads to changes in cardiovascular health and risk‑factor management over one year.
- Who it's for
- Adults aged 30‑75 in the Mass General Brigham primary‑care network who are not currently taking LDL‑cholesterol‑lowering medication.
- What's involved
- Participants receive their coronary artery disease polygenic risk score and are followed with routine health checks and questionnaires to track any changes in heart‑related risk factors.
- Time commitment
- The study lasts about one year and includes several clinic visits and assessments during that time.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 75
You may be able to join if
- Current age 30-75 years
- Established primary care at Mass General Brigham with at least one visit in the last 2 years
You likely can't join if
- \- Currently taking LDL cholesterol- lowering medications, including statins
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.